Latest News

 

New Weight Loss Treatments

Find out about new Anti-Obesity Medications

Setmelanotide licensed to treat children with genetic obesity from age 2

MC4R agonist now licensed for treatment of young children with POMC, PCSK1, LEPR deficiencies

Signal trial in acquired hypothalamic obesity

Start of new trial of LB54640, an oral MC4R agonist, in patients with hypothalamic obesity due to acquired hypothalamic injury

 

 
 

Latest News See all news>>

New Weight Loss Treatments

Find out about new Anti-Obesity Medications

Setmelanotide licensed to treat children with genetic obesity from age 2

MC4R agonist now licensed for treatment of young children with POMC, PCSK1, LEPR deficiencies

© Genetics of Obesity Study 2024 | Privacy Policy
Website by iDentityCreative